Non-Radical Diagnostic Biopsies Do Not Negatively Influence Melanoma Patient Survival

por Molenkamp, Barbara G., Sluijter, Berbel J. R., Oosterhof, Benny, Meijer, Sybren, van Leeuwen, Paul A. M.
Publicado 2007

Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized cli...

por de Gruijl, Tanja D, Koster, Bas D, van den Hout, Mari FCM, Sluijter, Berbel JR, Molenkamp, Barbara G, Vuylsteke, Ronald JCLM, van Leeuwen, Paul AM, Scheper, Rik J, van den Tol, Petrousjka, van den Eertwegh, Alfons
Publicado 2015

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread

por van den Hout, Mari F, Koster, Bas D, Scheper, Rik J, van de Ven, Rieneke, Sluijter, Berbel J, Molenkamp, Barbara G, van den Eertwegh, Alfons J, van Leeuwen, Paul A, van den Tol, Petrousjka M, de Gruijl, Tanja D
Publicado 2013

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma

por Koster, Bas D., de Jong, Tamarah D., van den Hout, Mari F. C. M., Sluijter, Berbel J. R., Vuylsteke, Ronald J. C. L. M., Molenkamp, Barbara G., Vosslamber, Saskia, van den Tol, M. Petrousjka, van den Eertwegh, Alfons J. M., de Gruijl, Tanja D.
Publicado 2019

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A(+)CD141(+) cDC1 and CD14(+) antigen-presenting cell recruitment

por Koster, Bas D, López González, Marta, van den Hout, Mari FCM, Turksma, Annelies W, Sluijter, Berbel JR, Molenkamp, Barbara G, van Leeuwen, Paul AM, Vosslamber, Saskia, Scheper, Rik J, van den Eertwegh, Alfons JM, van den Tol, M Petrousjka, Jordanova, Ekaterina J, de Gruijl, Tanja D
Publicado 2021